Palbociclib Formulation Test
Sponsors
Pfizer
Conditions
Healthy
Phase 1
A Study In Healthy Volunteers To Estimate The Effect Of The Active Ingredient Particle Size And Percentage Of The Excipients Used To Formulate The Capsules In The Dissolution Rate Of The Formulations In The Gastrointestinal Tract
CompletedNCT01844323
Start: 2013-06-30End: 2013-08-31Updated: 2013-08-28
Relative Bioavailability For Palbociclib Formulations
CompletedNCT02083640
Start: 2014-03-31End: 2014-05-31Updated: 2014-06-04